image2_Myostatin Promotes Osteoclastogenesis by Regulating Ccdc50 Gene Expression and RANKL-Induced NF-κB and MAPK Pathways.tif by Xin Zhi (1829224)

“…Specifically, myostatin increased the phosphorylation of Smad2, which led to the activation of NF-κB and MAPK pathways to activate osteoclastogenesis. Ccdc50 was identified as a gene whose expression was highly decreased in osteoclastogenesis upon myostatin treatment, and it could inhibit the function of myostatin in osteoclastogenesis by blocking NF-κB and MAPKs pathways. …”

image2_Myostatin Promotes Osteoclastogenesis by Regulating Ccdc50 Gene Expression and RANKL-Induced NF-κB and MAPK Pathways.tif by Xin Zhi (1829224)

“…Specifically, myostatin increased the phosphorylation of Smad2, which led to the activation of NF-κB and MAPK pathways to activate osteoclastogenesis. Ccdc50 was identified as a gene whose expression was highly decreased in osteoclastogenesis upon myostatin treatment, and it could inhibit the function of myostatin in osteoclastogenesis by blocking NF-κB and MAPKs pathways. …”

Among novel KOR antagonists, PF-04455242 stands out as activating a current. by Elyssa B. Margolis (7933838)

Estimation of the probability of contagion from epidemiological data. by Sergio Alonso (270169)

Supplementary Material for: Immunosuppressant Agents as Add-On Therapy Failed to Improve the Outcome of Immunoglobulin A Nephropathy with Crescent Score C1 by Bi X. (18245797)

“…Conversely, IgAN patients with C1 lesions and a cellular crescent ratio exceeding 50% treated with CS and immunosuppressant therapy experienced a significant improvement in renal function and a decline in urinary protein creatinine ratio. …”

Soluble membrane receptors, interleukin 6, procalcitonin and C reactive protein as prognostic markers in patients with severe sepsis and septic shock - Fig 1 by Juan-Jesús Ríos-Toro (3907732)

The editing at about 17% mitochondrial target Cs is defective in the <i>emp21</i> mutants. by Yong Wang (12837)

“…(B) The number of target Cs in WT maize mitochondria and of the abolished and decreased editing sites in the <i>emp21</i> and <i>emp5-1</i> mutants [<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1008305#pgen.1008305.ref018" target="_blank">18</a>]. …”

<i>skn-1</i> regulates sensory integration in <i>C</i>. <i>elegans</i>. by Mark A. Wilson (208472)

“…Sodium chloride chemotaxis was tested on a 5 mM gradient. The percentages of animals remaining at the origin in presence of NaCl (B), butanone (C), or the indicated concentrations of benzaldehyde (D), are shown. …”

GP41⁺ SPION⁺ MNGC in the CNS of an animal with AIDS and SIVE. by Zoey K. Wallis (17725175)

Description of kinematic variables measured during take-off to a jump. by Leena Inkilä (20614460)

Differences in abundance of lipid molecules in liver of <i>Fmo5</i>^<i>-/-</i> and WT mice. by Ian R. Phillips (5074121)

“…Red dots are lipids that are significantly increased or decreased in <i>Fmo5</i>^<i>-/-</i> mice with a -log₁₀ <i>q</i> above 1.301 (<i>q</i> <0.05) (grey line). …”

The life cycle-based CO₂ emissions from four technology-based categories of light-duty vehicles in GCAM/GLIMPSE from sales of new vehicles in 2030, (a) during lifetime,... by Pankaj Sadavarte (2012029)

Microarray amplification bias: loss of 30% differentially expressed genes due to long probe – poly(A)-tail distances-5 by Mirjam C Boelens (80125)

Effect of CXB and DMC combinations on P-glycoprotein protein content and activity of P-glycoprotein in HeLa (A) and SiHa cells (B). by Diana Xochiquetzal Robledo-Cadena (5265959)

Calculated cytoplasmic conductivities over [Na⁺] of suspending solutions at two desired temperatures. by Chadapust J. Sudsiri (14670602)

Maps showing changes in PC-level prevalence of (A) no-toilet households, (B) unimproved toilets, (C) shared toilets, and (D) private toilets between 2016 and 2021. by Anoop Jain (12095423)

Calculated SAR of cytoplasm of HRBC over [Na⁺] at standard laboratory benchmark temperature and normal body temperature. by Chadapust J. Sudsiri (14670602)

Changes in CRP and LDH levels over time. by Ekaterina A. Bryushkova (13360122)

Results of the evaluated LFAs and their performance parameters. by Ronald López (18098572)

CystC and Δ14CystC inhibit NMuMG cell proliferation and invasion by Jonathan P Sokol (27257)

“…<p><b>Copyright information:</b></p><p>Taken from "The use of cystatin C to inhibit epithelial–mesenchymal transition and morphological transformation stimulated by transforming growth factor-β"</p><p>Breast Cancer Research 2005;7(5):R844-R853.…”